Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Wanjin Chen, Shouwen Wang, Hongchuan Zhao, Guobin Wang, Rong Qin, Fan Huang, Wei Geng, Zimei Liu, Wei Wang, Ruolin Wu, Liujin Hou, Zhenghui Ye, Xinghua Zhang, Xiaoping Geng & Xiaojun Yu. (2023) High level of tumor marker CA19-9 returned to normal after cholecystectomy in calculous cholecystitis patients. Scandinavian Journal of Gastroenterology 58:6, pages 643-648.
Read now
Read now
Pekka Lahdenne & Markku Heikinheimo. (2002) Clinical use of tumor markers in childhood malignancies. Annals of Medicine 34:5, pages 316-323.
Read now
Read now
Boel Engarås, Larsolof Hafström, Jan Kewenter, Olle Nilsson & Hans Wedel. (1999) Standard Serum Concentrations and Normal Fluctuations of CEA, CA 50 and CA 242 during Twelve Months in Men and Women Aged 60-64 years without Malignant Disease. The European Journal of Surgery 165:2, pages 110-116.
Read now
Read now
Matti Eskelinen, Ulf Haglund. (1999) Developments in Serologic Detection of Human Pancreatic Adenocarcinoma. Scandinavian Journal of Gastroenterology 34:9, pages 833-844.
Read now
Read now
B. Pålsson, P. Masson & Å. Andrén-Sandberg. (1993) The Influence of Cholestasis on CA 50 and CA 242 in Pancreatic Cancer and Benign Biliopancreatic Diseases. Scandinavian Journal of Gastroenterology 28:11, pages 981-987.
Read now
Read now
Articles from other publishers (14)
Ming Shan, Qingwu Tian & Lijuan Zhang. 2019. Glycans and Glycosaminoglycans as Clinical Biomarkers and Therapeutics - Part A. Glycans and Glycosaminoglycans as Clinical Biomarkers and Therapeutics - Part A
187
198
.
Qi Xiao, Tianming Chen & Shilin Chen. (2018) Fluorescent contrast agents for tumor surgery (Review). Experimental and Therapeutic Medicine.
Crossref
Crossref
Kazuya Kato, Atsushi Nagase, Kazuhiko Onodera, Minoru Matsuda, Yoshiaki Iwasaki, Yurina Kato, Kimitaka Kato, Takako Kawakami, Masahiko Taniguchi & Hiroyuki Furukawa. (2011) Primary adenocarcinoma of the stomach in von Recklinghausen's disease with high serum levels of multiple tumor markers: a case report. Journal of Medical Case Reports 5:1.
Crossref
Crossref
Satu-Liisa Pauniaho, Olga Tatti, Pekka Lahdenne, Harry Lindahl, Mikko Pakarinen, Risto Rintala & Markku Heikinheimo. (2010) Tumor markers AFP, CA 125, and CA 19-9 in the long-term follow-up of sacrococcygeal teratomas in infancy and childhood. Tumor Biology 31:4, pages 261-265.
Crossref
Crossref
René Crepaldi-Filho, Rogério Tadeu Palma, Marcelo Franchini Giusti, Marina de Assis Galvão Bueno, Paulo Sérgio Lucas da Silva & Jaques Waisberg. (2008) Levels of carcinoembryonic antigen and CA 19-9 in the sera and peritoneal washing of patients undergoing surgical treatment for gastric carcinoma. Arquivos de Gastroenterologia 45:3, pages 219-224.
Crossref
Crossref
A K Khanna, S K Yadav, V K Dixit, G Nath, Mohan Kumar & Anuradha Khanna. (2016) CA 19-9 in Various Gastrointestinal Malignancies in an Indian Population. Tropical Doctor 34:2, pages 107-108.
Crossref
Crossref
Oliver Micke, Frank Bruns, Rene Kurowski, Eckehard Horst, Alexander F deVries, John W Hausler, Normann Willich & Ulrich Schäfer. (2003) Predictive value of carbohydrate antigen 19-9 in pancreatic cancer treated with radiochemotherapy. International Journal of Radiation Oncology*Biology*Physics 57:1, pages 90-97.
Crossref
Crossref
Carlos Rollhauser & William Steinberg. 1998. Pancreatic Cancer. Pancreatic Cancer
137
156
.
D. Pectasides, A. Mylonakis, M. Kostopoulou, M. Papadopoulou, D. Triantafillis, J. Varthalitis, M. Dimitriades & A. Athanassiou. (1997) CEA, CA 19-9, and CA-50 in Monitoring Gastric Carcinoma. American Journal of Clinical Oncology 20:4, pages 348-353.
Crossref
Crossref
Birger Plsson, Parvesh Masson & Åke Andrén-Sandberg. (1997) Tumour marker CA 50 levels compared to signs and symptoms in the diagnosis of pancreatic cancer. European Journal of Surgical Oncology (EJSO) 23:2, pages 151-156.
Crossref
Crossref
J Michael Tredger & Roy A Sherwood. (2016) The Liver: New Functional, Prognostic and Diagnostic Tests. Annals of Clinical Biochemistry: International Journal of Laboratory Medicine 34:2, pages 121-141.
Crossref
Crossref
Pentti A. Pasanen, Matti Eskelinen, Kaarina Partanen, Pekka Pikkarainen, Ilkka Penttil� & Esko Alhava. (1994) Tumour-associated trypsin inhibitor in the diagnosis of pancreatic carcinoma. Journal of Cancer Research and Clinical Oncology 120:8, pages 494-497.
Crossref
Crossref
Claudio Pasquali, Cosimo Sperti, Alfonso Alfano D’Andrea, Vincenzo Costantino, Chiara Filipponi & Sergio Pedrazzoli. (1994) Clinical value of seram TAG-72 as a tumor marker for pancreatic carcinoma. International journal of pancreatology 15:3, pages 171-177.
Crossref
Crossref
Matti Hakama, Ulf-Hakan Stenman, Paul Knekt, Jorma Järvisalo, Aila Leino, Timo Hakulinen, Jouni Maatela & Arpo Aromaa. (2016) Tumour Markers and Screening for Gastrointestinal Cancer: A Follow up Study in Finland. Journal of Medical Screening 1:1, pages 60-64.
Crossref
Crossref